We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$753M
2
JCI icon
Johnson Controls International
JCI
+$159M
3
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$53.2M
4
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$49.5M
5
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$47.2M

Top Sells

Rank Stock Value
1
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$562M
2
AVGO icon
Broadcom
AVGO
+$124M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$102M
4
UNP icon
Union Pacific
UNP
+$89.7M
5
MSFT icon
Microsoft
MSFT
+$75.1M

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCTX icon
3726
Lineage Cell Therapeutics
LCTX
$278M
$33.5K ﹤0.01%
23,769
+2,596
+12% +$3.59K
RXT icon
3727
Rackspace Technology
RXT
$1.18B
$33.3K ﹤0.01%
12,244
-253
-2% -$417
PRQR icon
3728
ProQR Therapeutics
PRQR
$265M
$33.3K ﹤0.01%
20,550
-2,000
-9% -$3.9K
NUVB icon
3729
Nuvation Bio
NUVB
$2.28B
$31.9K ﹤0.01%
17,710
-3,900
-18% -$6.63K
ICAD
3730
DELISTED
iCAD Inc
ICAD
$31.9K ﹤0.01%
19,546
– –
TCRT icon
3731
Alaunos Therapeutics
TCRT
$4.81M
$31.2K ﹤0.01%
408
– –
FUBO icon
3732
FuboTV Inc
FUBO
$282M
$31.1K ﹤0.01%
1,247
+128
+11% +$2.45K
WRAP icon
3733
Wrap Technologies
WRAP
$106M
$31.1K ﹤0.01%
21,300
-800
-4% -$1.02K
SFT
3734
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$31.1K ﹤0.01%
14,322
+119
+0.8% +$197
ET icon
3735
PUT
Energy Transfer Partners
ET
$71.6B
$30K ﹤0.01%
2,500
– –
INVZ icon
3736
Innoviz Technologies
INVZ
$115M
$30K ﹤0.01%
10,550
-350
-3% -$966
ME
3737
DELISTED
23andMe Holding Co
ME
$29.6K ﹤0.01%
847
+255
+43% +$10.2K
DWSN icon
3738
Dawson Geophysical
DWSN
$133M
$29.6K ﹤0.01%
14,593
– –
PAVMZ
3739
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$27.9K ﹤0.01%
174,542
-160,994
-48% -$20.8K
LX
3740
LexinFintech Holdings
LX
$244M
$27.3K ﹤0.01%
+11,900
New +$28.9K
SKYX icon
3741
SKYX Platforms
SKYX
$164M
$26.6K ﹤0.01%
+10,000
New +$32.1K
FRBK
3742
DELISTED
Republic First Bancorp Inc
FRBK
$25.9K ﹤0.01%
28,750
+12,500
+77% +$14.3K
LXRX icon
3743
Lexicon Pharmaceuticals
LXRX
$1.04B
$25.4K ﹤0.01%
+11,073
New +$29.4K
AZ icon
3744
A2Z Smart Technologies
AZ
$286M
$25.3K ﹤0.01%
4,000
– –
AIV
3745
CALL
Aimco
AIV
$383M
$25K ﹤0.01%
5,000
– –
FBIO icon
3746
Fortress Biotech
FBIO
$88M
$24.5K ﹤0.01%
2,965
– –
OPFI icon
3747
OppFi
OPFI
$593M
$23.9K ﹤0.01%
11,737
– –
ESPR
3748
DELISTED
Esperion Therapeutics
ESPR
$23.8K ﹤0.01%
17,136
+2,798
+20% +$3.91K
DNN icon
3749
Denison Mines
DNN
$3B
$23.8K ﹤0.01%
19,000
-41,140
-68% -$45.7K
CISO
3750
CISO Global
CISO
$12M
$23.3K ﹤0.01%
+8,728
New +$29.1K
148 149
150
151 152

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.